WA
CELG

Waverly Advisors’s Celgene Corp CELG Stock Holding History

Waverly Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,146
Closed -$213K – 141
2019
Q3 		$213K Buy
+2,146
New +$204K 0.03% 125
2019
Q2 		– Sell
-2,146
Closed -$202K – 132
2019
Q1 		$202K Buy
+2,146
New +$188K 0.03% 119
2018
Q3 		– Sell
-3,146
Closed -$250K – 198
2018
Q2 		$250K Buy
+3,146
New +$261K 0.04% 159
2018
Q1 		– Sell
-6,148
Closed -$642K – 401
2017
Q4 		$642K Buy
6,148
+2,546
+71% +$287K 0.09% 132
2017
Q3 		$525K Buy
3,602
+140
+4% +$19.1K 0.11% 132
2017
Q2 		$450K Sell
3,462
-60
-2% -$7.35K 0.11% 142
2017
Q1 		$438K Buy
+3,522
New +$421K 0.12% 140
2014
Q4 		– Sell
-1,371
Closed -$130K – 784
2014
Q3 		$130K Buy
1,371
+200
+17% +$18K 0.07% 114
2014
Q2 		$101K Sell
1,171
-1,171
-50% -$89.1K 0.04% 149
2014
Q1 		$163K Sell
2,342
-3,576
-60% -$283K 0.07% 106
2013
Q4 		$500K Buy
5,918
+2,178
+58% +$172K 0.18% 62
2013
Q3 		$288K Buy
3,740
+8
+0.2% +$561 0.15% 71
2013
Q2 		$218K Buy
+3,732
New +$225K 0.13% 88

Other funds holding CELG

HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Waverly Advisors's CELG Position: Q4 2019 in Review

Waverly Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,146 shares — an estimated $213K sold.

Waverly Advisors first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $642K in Q4 2017. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Waverly Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Waverly Advisors sold 2,146 Celgene Corp shares in Q4 2019, an estimated $213K.
  • Waverly Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
  • Waverly Advisors's Celgene Corp position peaked at $642K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Waverly Advisors's 13F filing for Q4 2019, filed 7 Feb 2020.